Synopsis
Classify an incidental or symptomatic bone lesion by age, site, matrix and biological behaviour, protect a weakened bone and avoid an unplanned biopsy or operation that compromises tumour care.
- Most benign bone lesions are incidental, but no lesion is safely labelled from name recognition alone: integrate age, exact skeletal site, margin, matrix, cortex and symptoms.
- First-line imaging is a high-quality radiograph in two planes including the full lesion; prior films are invaluable for growth and stability.
- A narrow geographic margin, intact cortex and uninterrupted solid periosteal response favour slow behaviour, whereas a permeative margin, cortical escape and mass are aggressive.
- MRI is the reference local-staging test for marrow extent, cartilage cap, neurovascular relation and soft-tissue component when biology or treatment requires clarification.
- CT best defines cortex and mineralised matrix, while bone scan or PET answers selected multiplicity or activity questions but cannot establish benign histology.
- Never biopsy, curette or internally fix a suspected primary bone tumour outside the specialist pathway; the incision and tract must be removable with definitive surgery.
- Protect weight bearing when a lesion causes functional pain, occupies substantial cortex or has fractured, and obtain tumour-aware orthopaedic advice before definitive fixation.
- Observe classic asymptomatic low-risk lesions with an explicit imaging plan; operate for fracture risk, pain attributable to the lesion, deformity, compression or uncertain/aggressive biology.
Key red flags
Night or rest pain that is progressive and not explained by a fracture is incompatible with casual discharge of an incidental benign label.
A wide or ill-defined transition zone, cortical breakthrough, aggressive periosteal reaction or soft-tissue mass requires specialist sarcoma review.
A pathological fracture through an uncharacterised lesion needs splintage and tumour-centre discussion before definitive fixation contaminates tissue planes.
Increasing size after skeletal maturity, new pain or a thick cartilage cap over an osteochondroma raises concern for secondary chondrosarcoma.
Multiple enchondromas, osteochondromas or cystic lesions require syndrome, deformity and malignant-risk assessment rather than isolated lesion treatment.
Spinal lesion with weakness, sensory change, gait dysfunction or bladder or bowel disturbance requires emergency MRI and spinal surgical input.
Investigation priorities
Characterise location, margin, matrix, cortex, periosteal response and fracture and compare with prior imaging.
Management branches
A bone lesion appears unexpectedly on imaging obtained for another reason.
- Review high-quality radiographs, patient age, precise location, margin, matrix and all prior images.
- Ask directly about focal pain, growth, fracture, constitutional symptoms and relevant cancer or family history.
- Discharge only a confidently characteristic no-risk variant; otherwise define interval imaging or specialist review explicitly.
- Escalate any aggressive or clinically discordant feature to the bone-tumour service before local intervention.